GUJARAT CORONA UPDATE 14 SEPTEMBER 2020

GUJARAT CORONA UPDATE 14 SEPTEMBER 2020

Amid rising cases of corona virus, the central government has indicated that the corona vaccine for the high-risk group, the elderly and frontline workers, could soon be approved. So far no date has been announced for the launch of the vaccine. However, Health Minister Harshvardhan has expressed hope that the vaccine will be available before March next year. US company Pfizer, on the other hand, claims that its vaccine will be available in the US market before December this year. You also know what is being developed around the world on the vaccine that is waiting to overcome the corona.

India can also go the way of Russia and China

"The government may soon approve the vaccine for the high risk group, the elderly and frontline workers," Union Health Minister Harshvardhan told a social media program on Sunday. Efforts are underway to get everyone to agree on it.
Harshvardhan's remarks are a clear indication that India, through Russia and China, may soon approve the vaccine for the high-risk group. Russia has given emergency approval to its vaccine SPUTNIK V and China to its 3 vaccines.
Trials of three vaccines are underway in India. India is developing biotech and ICMR covacin. Ahmedabad-based company Zydus Cadila's vaccine is in Phase-2 trial. The Serum Institute of India in Pune is conducting a Phase-2 and Phase-3 trial of Oxford / AstraZeneca's Covishield.
It may take four to five years for the vaccine to be delivered worldwide

"The vaccine will not be available to everyone in the world by the end of 2014," Adar Poonawala, CEO of Serum Institute, the world's largest vaccine manufacturing company, said in an interview. He said it would take four to five years to deliver the vaccine everywhere in every country.
The company has partnered with five companies, including AstraZeneca and Novavex, Poonawala told the Financial Times. Is preparing to make a billion doses. Half of them will be available in India. The company is also planning to partner with Russia's Gamaleya Research Institute to produce SPUTNIK V.

The Oxford / AstraZeneca vaccine trial was stopped in the UK after one person fell ill. But the good news is that the trial of the vaccine is starting again in Britain. The company has received approval for it. The Serum Institute of India is currently awaiting approval from the Drug Regulator in India to resume the trial. The Drug Regulator had sent a notice to the Serum Institute stating the reason. The answer has been sent by the Serum Institute. The stalled trials of Kovishield will resume in India soon. However, no official statement has been released yet.
Pfizer's CEO said Americans will get the vaccine this year

Phase-3 trials of the vaccine made by the American company Pfizer and the German company Bioentech are underway in the United States. The company claims that it has stepped up efforts to bring the vaccine to the US market this year.
"We've started manufacturing, we've already made thousands of doses," Pfizer CEO Albert Bourla told the CBS TV network. If the results of our trials are good, it will not take long for the vaccine to hit the market.
Pfizer said earlier that it would be known by October whether the vaccine was safe and effective. Baurla repeated the same thing in his interview. He said there was a 60% chance that the company would know by October how effective the vaccine was.
What does the WHO vaccine landscape say?

Currently 180 vaccines are being developed around the world.
35 vaccines are under clinical trial.
The 9 vaccine is in phase-3 i.e. final round trial. Four vaccines are also being developed in China.
The 145 vaccine is in the phase of pre-clinical trials. That is, their evaluation is still going on in the labs.